IL17A and synovial sarcoma: Abnormal activation of T and B cells, particularly by cytokines associated with Th17 cells, such as interleukin (IL)−17 and IL-23, along with inflammatory responses driven by B cell–related factors, such as TNF and BAFF, are key contributors to the development of SS [6, 7].